(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide
CAS: 1802706-04-2
Ref. 3D-CXC70604
Tamanho indefinido | Descontinuado |
Informação sobre produto
(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide is a drug candidate for the treatment of lymphocytic leukemia and other cancers. It has shown inhibitory effects on cardiac cells that are not present in primary cells or cancer cells. This drug also has been shown to have an antiangiogenic effect on pancreatic cancer and chronic lymphocytic leukemia. (7S)-N-[5-(ethylsulfonyl)-2-pyridinyl]methyl]-6, 7-dihydro-7-(1 -methylethyl)-6-[(trans, trans 4